Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Cardiologists develop new way to evaluate heart risks—kidney function, metabolic health included for first time

One key difference between this new risk calculator and previous methods is that it does not consider a patient's race or ethnicity. It does, however, consider such factors as where the patient lives, their education and their income level. 

older patient with a doctor at their house

Ross procedure still linked to ‘excellent’ outcomes as patients enter third decade after surgery

Researchers focused on more than 100 patients who underwent the Ross procedure from 1994 to 2001, sharing their findings in JAMA Cardiology.

PHOTO GALLERY: Interventional cardiology technologies at TCT 2023

Browse through some of the many highlights from TCT 2023 in San Francisco.

tirzepatide injections Zepbound Eli Lilly

FDA approves diabetes drug tirzepatide for chronic weight management under new name

The FDA issued its own statement about the approval, highlighting the importance of taking the drug in combination with an improved diet and regular physical activity.  

Matthias Götberg discusses iFR vs. FFR from the National SWEDEHEART Quality Registry at #TCT2023. #iFR

iFR and FFR are equal, new long-term analysis confirms

There were some concerns among researchers after one study suggested iFR may increase the risk of mortality. New data presented at TCT 2023, however, showed that the two technologies are linked to similar outcomes. 

Ultromics EchoGo AI platform

CMS increases reimbursement for AI-powered heart failure platform

Ultromics thinks the significant payment increase will help ramp up utilization among U.S. healthcare providers.

Recor Medical's Paradise Ultrasound Renal Denervation System

FDA approves first renal denervation system for uncontrolled hypertension

The system, designed for patients with uncontrolled hypertension who are unresponsive to medication, uses ultrasound ablation to target nerves in the renal arteries, increasing blood flow. This approval comes just months after an FDA advisory panel voted in favor of the system. 

ChatGPT tackles hypertension: Popular AI model a helpful resource for patients with high blood pressure

The study's authors communicated with ChatGPT-4 in both English and Japanese, noting that it appeared to struggle more with the complexities of the Japanese language.